期刊文献+

肿瘤多药耐药逆转剂研究新进展 被引量:3

The new process of multidrug resistance reversal agents
下载PDF
导出
摘要 肿瘤耐药逆转剂的研究是抗肿瘤药物研究的重要策略。目前处于临床试验阶段的新逆转剂有Tariquidar(XR9576)、Zosuquidar(LY335979)、Laniquidar(R101933)、ONT-093、Elacridar(GF1210918)等,它们通过直接与P-gP结合,使P-gP丧失外排药物功能,从而抑制抗癌药物自胞内泵出细胞外,增加细胞内抗癌药物的积聚,逆转多药耐药性。新近发现一种治疗高血压和冠心病的β-肾上腺素受体阻断剂卡维地洛可以逆转肿瘤细胞对抗肿瘤药物的多药耐药,其逆转活性可与维拉帕米相当。
作者 徐峰 蔡卓夫
出处 《中国药物应用与监测》 CAS 2004年第3期57-59,共3页 Chinese Journal of Drug Application and Monitoring
基金 广东省医学科研基金资助项目(A2003471)
  • 相关文献

参考文献22

  • 1[1]Goldman B. Multidrug resistance:can new drugs help chemotherapy score against cancer[J]. J Natl Cancer Inst,2003,95 (4):255.
  • 2[2]Matteru J. Drug resistance in cancer: a multifactorial problem [J].Anticancer Res,2003,23 ( 2C ):1769.
  • 3[3]Bush JA,Li G. Cancer chemoresistance.the relationship between p53 and multidrug transporters[J]. Int J Cancer, 2002,98(3):323.
  • 4[4]Tsuruo T,Naito M,Tomida A,et al. Molecular targeting therapy of cancer:drug resistance,apoptosis and survival signal[J]. Cancer Sci,2003,94(1):15.
  • 5[5]Varma MV,Ashokraj Y,Dey CS,et al.P-glycoprotein inhibitors and their screening:a perspective from bioavailability enhancement [J]. Pharmacol Res, 2003,48 ( 4 ) :347.
  • 6[6]Thomas H,Coley HM.Overcoming multidrug resistance in cancer:an update on the clinical strategy of inhibiting p-glycoprotein [J]. Cancer Control, 2003, 10 ( 2 ) :159.
  • 7[7]Sharma R,Awasthi YC,Yang Y,et al. Energy dependent transport of xenobiotics and its relevance to multidrug resistance[J]. Curr Cancer Drug Targets, 2003,3 ( 2 ) :89.
  • 8[8]Sparreboom A,Danesi R,Ando Y,et al. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy[J]. Drug Resist Update,2003,6 ( 2 ) :71.
  • 9刘苓霜,田建辉,施志明.中药逆转肿瘤多药耐药研究进展[J].中医研究,2003,16(1):43-45. 被引量:4
  • 10[10]Liu ZL,Hirano T,Tanaka S,et al. Persistent reversal of Pglycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4cells[J]. J Pharm Pharmacol, 2003,55 ( 11 ) :1531.

二级参考文献20

共引文献3

同被引文献11

  • 1陈俊,张积仁,肖明星,余志坚,陈春.P糖蛋白抑制X射线诱导凋亡及对线粒体膜电位的影响[J].中华放射医学与防护杂志,2004,24(4):297-299. 被引量:9
  • 2Johnstone RW,Ruefli AA,Smyth MJ.Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem Sci,2000,25:1-6.
  • 3Johnstone RW,Ruefli AA,Tainton KM,et al.A role for pglycoprotein in regulating cell death.Leuk Lymphoma,2000,38:1-11.
  • 4Ruth AC,Roninson IB.Effects of the multidrug transporter pplycoprotein on cellular responses to ionizing radiation.Cancer Res,2000,60:2576-2578.
  • 5Trindade GS,Capella LS,Affonso M,et al.Differences in sensitivity to UVC,UVB and UVA radiation of a multidrug-resistant cell line overexpressing p-glycoprotein.Photochem Photobiol,1999,69:694-699.
  • 6Smyth M J,Krasovskis E,Sutton VR,et al.The drug efflux protein,Pglycoprotein,additionally protects drug-resistant tumor cells from multiple forms of caspasc-dependent apoptosis.Proc Natl Acad Sci USA,1998,95:7024-7029.
  • 7Ng IO,Lam KY,Ng M,et al.Expression of P-glycoprotein,a multidrug-resistance gene product,is induced by radiotherapy in patients with oral squamous cell carcinoma.Cancer,1998,83:851-857.
  • 8Ruefli AA,Tainton KM,Darcy PK,et al.P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation.Cell Death Differ,2002,9:1266-1272.
  • 9Brenner C,Kroemer G.Apoptosis:mitochondria-the death signal integrators.Science,2000,289:1150-1151.
  • 10Ella B,Donald D,Doualas RG,et al.Mithchondrial Cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization.EMBOJ,1998,17:37-49.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部